How to save Medicare: the anti-aging remedy.
The unprecedented progress in aging research has revealed that rapamycin, a clinically approved drug, is actually an anti-aging agent, which potentially could be employed to delay age-related diseases, thus extending healthy life span. The possibility of preventing diseases by staying young is remarkable in itself. At the same time this advance could save Medicare as we know it. Here I discuss how anti-aging interventions could solve otherwise intractable political problems without tax increases or curtailment of health care benefits.
Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. blagosklonny@oncotarget.com
Mikhail V
MV
Blagosklonny
D000375:Aging / Q000187:drug effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D008136:Longevity / Q000187:drug effects; D006278:Medicare / Q000191:economics*; D020123:Sirolimus / Q000494:pharmacology* / Q000627:therapeutic use; D014481:United States
D007166:Immunosuppressive Agents; D020123:Sirolimus